Evaxion Biotech A/S - stock earnings
EVAX Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 29, 2024 BeforeMarket | - / -0.5500000000 | - | - / 40000 | - |
EVAX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -5.7 million USD | ? USD |
2023Q2 | -5.7 million USD | ? USD |
2023Q1 | -6.9 million USD | ? USD |
2022Q4 | -6.9 million USD | ? USD |
2022Q3 | -5.7 million USD | ? USD |
2022Q2 | -4.8 million USD | ? USD |
2022Q1 | -5.8 million USD | ? USD |
2021Q4 | -8.4 million USD | ? USD |
2021Q3 | -5.3 million USD | ? USD |
2021Q2 | -6.8 million USD | ? USD |
2021Q1 | -4.3 million USD | ? USD |
2020Q4 | -4.3 million USD | ? USD |
2020Q3 | -4.0 million USD | ? USD |
2020Q2 | -3.6 million USD | ? USD |
2020Q1 | -3.1 million USD | ? USD |
2019Q4 | -3.5 million USD | ? USD |
EVAX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -24.5 million USD | ? USD |
2022 | -23.2 million USD | ? USD |
2021 | -24.5 million USD | ? USD |
2020 | -15.0 million USD | ? USD |
2019 | -11.2 million USD | ? USD |
2018 | -5.5 million USD | ? USD |
EVAX
Price: $3.95
52 week price:
Earnings Per Share: -8.10 USD
P/E Ratio: -0.42
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 302177
Market Capitalization: 21.3 million